Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 +0.80%83 Price-to-Tangible-Book is 2.19 as of Aug. 28, 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 83/100 and a GF Value™ of R$5.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 505 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 56.83% on this metric.
The historical rank and industry rank for Hospital Mater Dei's Price-to-Tangible-Book or its related term are showing as below:
BSP:MATD3'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.73 Med: 2.2 Max: 508.44
Current: 2.19
During the past 9 years, Hospital Mater Dei's highest Price to Tangible Book Ratio was 508.44. The lowest was 1.73. And the median was 2.20.
BSP:MATD3's Price-to-Tangible-Book is ranked better than 56.83% of 505
companies
in the Healthcare Providers & Services industry
Industry Median: 2.65
vs BSP:MATD3: 2.19
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Hospital Mater Dei Price-to-Tangible-Book Related Terms
Hospital Mater Dei Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: Price-to-Tangible-Book Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Hospital Mater Dei (BSP:MATD3) has a Price-to-Tangible-Book of 2.19 as of Aug. 28, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Hospital Mater Dei and its competitors. According to the industry distribution chart, Hospital Mater Dei ranks #218 out of 505 companies in the Healthcare Providers & Services industry, placing it in the top 43.2%.
Is Hospital Mater Dei's Price-to-Tangible-Book too high?
Hospital Mater Dei's current Price-to-Tangible-Book is 2.19. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.65. Hospital Mater Dei's value of 2.19 is 17.4% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #218 out of 505 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Price-to-Tangible-Book compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #218 out of 505 companies for Price-to-Tangible-Book. This puts Hospital Mater Dei in the upper half of its industry. The industry median Price-to-Tangible-Book is 2.65. Hospital Mater Dei's value of 2.19 is 17.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.65, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Price-to-Tangible-Book of 2.19 is 17.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Price-to-Tangible-Book is 2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.68, compared to a current price of R$5.05 — trading 11.1% below its estimated fair value. The current Price-to-Tangible-Book is 2.19 and 17.4% below the Healthcare Providers & Services industry median of 2.65. Hospital Mater Dei's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Price-to-Tangible-Book is 2.19 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$5.05 is trading 11.1% below its estimated GF Value™ of R$5.68.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Price-to-Tangible-Book: 2.19
GF Value™: R$5.68 vs. price of R$5.05 (11.1% below fair value)
Industry Position: 17.4% below the Healthcare Providers & Services median (#218 of 505)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
83GF Score
Get the complete analysis for BSP:MATD3
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
